266 related articles for article (PubMed ID: 24445092)
1. Contrast-enhanced ultrasound using real-time contrast harmonic imaging in invasive breast cancer: comparison of enhancement dynamics with three different doses of contrast agent.
Saracco A; Szabó BK; Aspelin P; Leifland K; Tánczos E; Wilczek B; Axelsson R
Acta Radiol; 2015 Jan; 56(1):34-41. PubMed ID: 24445092
[TBL] [Abstract][Full Text] [Related]
2. Bolus compared with continuous infusion of microbubble contrast agent using real-time contrast harmonic imaging ultrasound in breast tumors.
Saracco A; Aspelin P; Leifland K; Themudo R; Wilczek B; Axelsson R
Acta Radiol; 2009 Oct; 50(8):854-9. PubMed ID: 19634024
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between benign and malignant breast tumors using kinetic features of real-time harmonic contrast-enhanced ultrasound.
Saracco A; Szabó BK; Aspelin P; Leifland K; Wilczek B; Celebioglu F; Axelsson R
Acta Radiol; 2012 May; 53(4):382-8. PubMed ID: 22434928
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced ultrasound characteristics of breast cancer: correlation with prognostic factors.
Cao XL; Bao W; Zhu SG; Wang LH; Sun MH; Wang L; Men YM; Xue J
Ultrasound Med Biol; 2014 Jan; 40(1):11-7. PubMed ID: 24207087
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
[TBL] [Abstract][Full Text] [Related]
6. Enhancement patterns and parameters of breast cancers at contrast-enhanced US: correlation with prognostic factors.
Wan CF; Du J; Fang H; Li FH; Zhu JS; Liu Q
Radiology; 2012 Feb; 262(2):450-9. PubMed ID: 22282183
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.
Li N; Ding H; Fan P; Lin X; Xu C; Wang W; Xu Z; Wang J
Ultrasound Med Biol; 2010 Jul; 36(7):1066-75. PubMed ID: 20620694
[TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of microvascular blood flow by contrast-enhanced ultrasound (CEUS).
Greis C
Clin Hemorheol Microcirc; 2011; 49(1-4):137-49. PubMed ID: 22214685
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
[TBL] [Abstract][Full Text] [Related]
10. Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound.
Wang Y; Fan W; Zhao S; Zhang K; Zhang L; Zhang P; Ma R
Eur J Radiol; 2016 Jan; 85(1):48-54. PubMed ID: 26724648
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy.
Nemec U; Nemec SF; Novotny C; Weber M; Czerny C; Krestan CR
Eur Radiol; 2012 Jun; 22(6):1357-65. PubMed ID: 22322310
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.
Saracco A; Szabó BK; Tánczos E; Bergh J; Hatschek T
Acta Radiol; 2017 Apr; 58(4):394-402. PubMed ID: 27461224
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of the impact of ultrasound scanner settings and contrast bolus volume on time-intensity curves.
Gauthier TP; Chebil M; Peronneau P; Lassau N
Ultrasonics; 2012 Jan; 52(1):12-9. PubMed ID: 21722933
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced ultrasound in the characterization of complex cystic focal liver lesions.
Corvino A; Catalano O; Setola SV; Sandomenico F; Corvino F; Petrillo A
Ultrasound Med Biol; 2015 May; 41(5):1301-10. PubMed ID: 25666723
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasonographic findings of different histopathologic types of breast cancer.
Wang X; Xu P; Wang Y; Grant EG
Acta Radiol; 2011 Apr; 52(3):248-55. PubMed ID: 21498359
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic efficacy of contrast-enhanced sonography by combined qualitative and quantitative analysis in breast lesions: a comparative study with magnetic resonance imaging.
Wang L; Du J; Li FH; Fang H; Hua J; Wan CF
J Ultrasound Med; 2013 Oct; 32(10):1805-14. PubMed ID: 24065262
[TBL] [Abstract][Full Text] [Related]
17. Optimization of Region of Interest Drawing for Quantitative Analysis: Differentiation Between Benign and Malignant Breast Lesions on Contrast-Enhanced Sonography.
Nakata N; Ohta T; Nishioka M; Takeyama H; Toriumi Y; Kato K; Nogi H; Kamio M; Fukuda K
J Ultrasound Med; 2015 Nov; 34(11):1969-76. PubMed ID: 26384607
[TBL] [Abstract][Full Text] [Related]
18. Papillary renal cell carcinoma and clear cell renal cell carcinoma: Differentiation of distinct histological types with contrast - enhanced ultrasonography.
Xue LY; Lu Q; Huang BJ; Li Z; Li CX; Wen JX; Wang WP
Eur J Radiol; 2015 Oct; 84(10):1849-56. PubMed ID: 26149528
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
[TBL] [Abstract][Full Text] [Related]
20. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
